AVID and beyond: Lessons learned

Journal of Interventional Cardiology

Volumn 11, Issue 3, 1998, Pages 217-226

  Cannom, David S ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SOTALOL;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DRUG EFFICACY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031776566     PISSN: 08964327     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8183.1998.tb00122.x     Document Type: Article

References (28)

1. Mitchell LB. Clinical trials of antiarrhythmic drugs in patients with sustained ventricular tachyarrhythmias. Curr Opin Cardiol 1997;12:33-40.
2. Anderson JL. Implantable defibrillators are preferable to pharmacologic therapy for patients with ventricular tachyarrhythmias: An antagonist's viewpoint. Prog Cardiovasc Dis 1996;37:393-400.
3. Saksena S, Madon N, Lewis C. Implantable cardioverter defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias. Prog Cardiovasc Dis 1996;38:445-454.
4. Kim SG. Evolution of the management of malignant ventricular tachyarrhythmias: The roles of drug therapy and implantable defibrillators. Am Heart J 1995; 130:1144-1150.
5. Böcker D, Breithardt G, Block M, et al. Management of patients with ventricular tachyarrhythmias: Does an optimal therapy exist? PACE 1994;17:559-570.
6. Böcker D, Block M, Borggrefe M, et al. Defibrillators are superior to antiarrhythmic drugs in treatment of ventricular tachyarrhythmias. Eur Heart J 1997;18:26-30.
7. Zipes DP. Are implantable cardioverter defibrillators better than the conventional antiarrhythmic drugs for survivors of cardiac arrest? Circulation 1995;91:2115-2117.
8. Mirowski M, Reid PR, Winkle RA, et al. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585-588.
9. Winkle RA, Mead RH, Ruder MA, et al. Long term outcome with the automatic implantable cardioverter defibrillator. J Am Coll Cardiol 1989;13:1353-1361.
10. Thomas AC, Moser SA, Smutka ML, et al. Implantable defibrillation: Eight years clinical experience. PACE 1988;11:2053-2058.
11. Fogoros RN, Fielder, SB, Ellison JJ. The automatic implantable cardioverter defibrillator in drug refractory ventricular arrhythmias. Ann Intern Med 1987;107:635-341.
12. Newman D, Suave MJ, Herre J, et al. Survival after implantation of a cardioverter defibrillator. Am J Cardiol 1992;69:899-903.
13. Powell AC, Fuchs TE, Finkelstein DM, et al. Influence of implantable cardioverter defibrillators and long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092.
14. Böcker D, Haverkamp W, Block M, et al. Comparison of d, Isotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease. Circulation 1996;94:151-157.
15. Kim SG. Implantable defibrillator therapy: Does it really prolong life? How can we prove it? Am J Cardiol 1993;71:1213-1218.
16. Sirigh BN. Implantable cardioverter defibrillators: Note the ultimate gold standard for gauging therapy of VT/fibrillation. Am J Cardiol 1994;73:1211-1213.
17. Zipes DP. Implantable cardioverter defibrillator. Lifesaver or a device looking for a disease. Circulation 1994;89:2934-2936.
18. Cox JL. Patient selection criteria and results of surgery for refractory ischemic ventricular tachycardia. Circulation 1989;79(suppl I):163-177.
19. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
20. Kim SG, Hallstrom A, Love JC, et al. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the antiarrhythmics vs implantable defibrillators (AVID) trial and nonrandomized registry patients. Am J Cardiol 1997;80:454-457.
21. Fogoros RN, Ellison JJ, Bonnet CA, et al. Actual incidence and pattern of recurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. PACE 1989;9:1465-1473.
22. Pinski SL, Yao Q, Cook JR, et al. Baseline prognostic indicators in patients with sustained ventricular tachyarrhythmias: The Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Registry. Circulation 1997;96(8)suppl:I-335.
23. Halperin BD, Brodsky M, Lancaster S, et al. Prognostic value of baseline electrophysiology studies - The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. Circulation 1997;96(8)suppl:I-334.
24. Steinberg JS, Cannom DS, Marinchak R, et al. Dilated cardiomyopathy versus coronary artery disease in patients with VT/VF: Differences in presentation and outcome in the antiarrhythmics versus implantable defibrillators (AVID) registry. Circulation 1997;96(8)suppl:I-715.
25. Moss AJ, Hall WJ, Cannom DS, et al. improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
26. Peter Friedman. Unpublished data.
27. Bigger JT, for The CABG-Patch Trial Investigators: Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 1997;337:1569-1575.
28. Lehmann MH, Saksena S for the NASPE Policy Conference Committee. Implantable cardioverter defibrillators in cardiovascular practice: Report of the policy conference of the North American Society of Pacing and Electrophysiology. PACE 1991;14:969-979.